After an 80-year gap, human trials of a new tuberculosis vaccine are due to
start. If the vaccine is successful it could save millions of lives each year.
TB jabs use a weakened form of the bacterium that causes the disease in
cows—Bacille Calmette-Guérin. BCG gives good protection for about
10 years but then it wears off, and booster shots have little effect. Now Helen
McShane at the John Radcliffe Hospital in Oxford is starting trials with a
modified cowpox virus that carries a TB antigen. Used as a booster after BCG,
the new vaccine should give a much better immune response, she says.
More from New Ä¢¹½Ö±²¥
Explore the latest news, articles and features
Technology
Laser weapons have come of age and are making their way to the battlefield
News
Society
Timeline: The biggest breakthroughs of the past 70 years
Features
Space
We now know how radiation destroys electronics devices
News
Society
“The gut microbiome will become part of every person’s medical record”
Features
Popular articles
Trending New Ä¢¹½Ö±²¥ articles